A Year of Continued Growth and Success
A Year of Continued Growth and Success
复制标题
DOI：
10.1093/neuonc/nor225
复制
发表时间：
2012
期刊：
影响因子：
15.9
通讯作者：
W. Yung
中科院分区：
文献类型：
--
作者：
W. Yung
2011年是神经肿瘤学的又一个强劲年份。预计到2011年底，该杂志将收到约658篇论文，较2010年的582篇和2009年的576篇有大幅增长。2010年，该杂志开始每月出版一次。《神经肿瘤学》的免费在线访问被添加到欧洲神经肿瘤学协会的会员福利中，进一步增加了该杂志的发行和曝光率，我们的网站的移动版本也可用了。我们也很高兴地报告，尽管我们持续增长，但我们的质量标准仍然很高，这反映在我们2010年的影响因子为5.483。这一数字由Thomson Scientific每年在《期刊引用报告》（Journal Citation Reports）中发布，大大高于2009年报告的4984篇，表明该期刊在转型和波动期间的引用率有所提高。《神经肿瘤学》目前在185种肿瘤学期刊中排名第24位，在185种临床神经病学期刊中排名第15位。从第14卷开始，神经肿瘤学将开始要求所有提交的手稿的结构化摘要（组织成背景，方法，结果和结论部分）。我们相信，这将使论文更容易审查和索引。我们要求所有作者在提交文章以供考虑时，请牢记这种新格式。图1所示。神经肿瘤学自2002年以来的影响因子。2008年，该杂志从季刊改为双刊，2010年改为月刊。2010年的影响因子为5.483，反映了2008年和2009年发表的论文。《神经肿瘤学》感谢我们的编委会成员（他们的名字出现在每期杂志上）和其他同行审稿人的不懈努力，他们帮助我们取得了成功（下面列出的是那些同意在10月31日之前进行手稿审稿的审稿人）。我们也感谢我们的作者和读者对杂志的宝贵贡献。直到阿克·曼尼什·阿吉·弗朗西斯·阿里-奥斯曼·杰弗里·艾伦，MD James Michael Angelastro Terri S. Armstrong Joachim M. Baehring Ute Bartels Michael Brada Cameron W. Brennan Dan Cahill Steven L. Carroll Craig Castellino Marc C. Chamberlain Susan Chi Jennifer Clarke Elizabeth Brooks Claus Charles Cobbs Kenneth J. Cohen Courtney Crane Faith G. Davis Linda Douw Joan enggebretson Bradley Erickson Graziella Filippini John C. Flickinger Nicholas Foreman高光藤木三木藤田Caterina Giannini Richard J. Gilbertson Kristine Glunde Stewart GoldmanCandelaria Gomez-Manzano Vidya Gopalakrishnan Morris Groves Nalin Gupta Marlan Hansen Christian Hartmann Cynthia Hawkins John W. Henson Christal herlow - mende Ulrich Herrlinger Kenneth Hess Yuichi Hirose Khe hoangxuan Leland Hu Suyun Huang Peter D. Inskip Andreas H. Jacobs Randy Jensen Tao Jiang Jeno Viktor Julow Bernd Kaina Daniel Kamei Yukinari Kato Timothy Kaufmann Santosh Kesari Helmut kettenmann Peter Krauseneck Ashok Kumar Lawrence Lamb Heiner Langermann Florence Lefranc Maciej LesniakMaria Lopes Lorenzo maggrassi James M. Markert Warren Mason Masao Matsutani Ian E. McCutcheon Roger mcclendon Alex McMillan Kazuhiko Mishima Sabine Mueller Do-Hyun Nam Gila Neta Edward A. Neuwelt Theo Nicolaides Andrew Norden Terry Parker Andrew T. Parsa Vinay K. Puduvalli Zvi Ram Jaap C. Reijneveld Sabrina Ronen Joshua B. Rubin Raymond Sawaya Davide Schiffer S. Clifford Schold小Walter Stummer Ghazaleh Tabatabai Shingo Takano Christina tsiaaki Yanagisawa Seiichi Yoshida张伟编辑部对任何疏忽表示歉意。
2011 was another strong year for Neuro-Oncology. The journal is projected to receive approximately 658 papers by the end of 2011, a substantial increase from 582 in 2010, when the journal began to be published monthly, and 576 in 2009. Free online access to Neuro-Oncology was added to the membership benefits of the European Association of Neuro-Oncology, further increasing the journal's distribution and exposure, and a mobile version of our website became available. We are also pleased to report that our quality standard has remained high despite our continued growth, as reflected by our 2010 impact factor number of 5.483. This figure, released annually by Thomson Scientific in the Journal Citation Reports, is substantially higher than the 4.984 reported in 2009 and demonstrates an improved citation rate during a period of transition and flux for the journal. Neuro-Oncology is now ranked 24th of 185 oncology journals and 15th of 185 clinical neurology journals. Starting with volume 14, Neuro-Oncology will begin requiring structured abstracts (organized into Background, Methods, Results, and Conclusions sections) for all submitted manuscripts. We believe that this will make papers easier to review and index. We ask that all authors please keep this new format in mind when submitting their articles for consideration.consideration. Fig. 1. Neuro-Oncology's impact factors since 2002. The journal switched from quarterly publication to bimonthly in 2008 and to monthly in 2010. The 2010 impact factor of 5.483 reflects papers published in 2008 and 2009. Neuro-Oncology is indebted to the tireless members of our editorial board (whose names appear in every issue of the journal) and other peer reviewers for helping us succeed (listed below are those reviewers who had agreed to conduct manuscript reviews as of October 31). We also thank our authors and readers for their ongoing valuable contributions to the journal. Till Acker Manish Aghi Francis Ali-Osman Jeffrey Allen, MD James Michael Angelastro Terri S. Armstrong Joachim M. Baehring Ute Bartels Michael Brada Cameron W. Brennan Dan Cahill Steven L. Carroll Craig Castellino Marc C. Chamberlain Susan Chi Jennifer Clarke Elizabeth Brooks Claus Charles Cobbs Kenneth J. Cohen Courtney Crane Faith G. Davis Linda Douw Joan Engebretson Bradley Erickson Graziella Filippini John C. Flickinger Nicholas Foreman Takamitsu Fujimaki Mitsugu Fujita Caterina Giannini Richard J. Gilbertson Kristine Glunde Stewart Goldman Candelaria Gomez-Manzano Vidya Gopalakrishnan Morris Groves Nalin Gupta Marlan Hansen Christian Hartmann Cynthia Hawkins John W. Henson Christal Herold-Mende Ulrich Herrlinger Kenneth Hess Yuichi Hirose Khe Hoang-Xuan Leland Hu Suyun Huang Peter D. Inskip Andreas H. Jacobs Randy Jensen Tao Jiang Jeno Viktor Julow Bernd Kaina Daniel Kamei Yukinari Kato Timothy Kaufmann Santosh Kesari Helmut Kettennmann Peter Krauseneck Ashok Kumar Lawrence Lamb Heiner Langermann Florence Lefranc Maciej Lesniak Maria Lopes Lorenzo Magrassi James M. Markert Warren Mason Masao Matsutani Ian E. McCutcheon Roger McLendon Alex McMillan Kazuhiko Mishima Sabine Mueller Do-Hyun Nam Gila Neta Edward A. Neuwelt Theo Nicolaides Andrew Norden Terry Parker Andrew T. Parsa Vinay K. Puduvalli Zvi Ram Jaap C. Reijneveld Sabrina Ronen Joshua B. Rubin Raymond Sawaya Davide Schiffer S. Clifford Schold, Jr. Walter Stummer Ghazaleh Tabatabai Shingo Takano Christina Tsien Takaaki Yanagisawa Seiichi Yoshida Wei Zhang The editorial office apologizes for any inadvertent omissions.